We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $4.11B
1-Year Est. Return 21.98%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+21.98%
3 Year Est. Return
+96.16%
5 Year Est. Return
+100.81%
10 Year Est. Return
+306.64%
AUM
$4.42B
AUM Growth
+$835M
Cap. Flow
+$113M
Cap. Flow %
2.55%
Top 10 Hldgs %
47.33%
Holding
1,313
New
733
Increased
204
Reduced
127
Closed
224

Sector Composition

Rank Sector Weight
1 Miscellaneous 78.84%
2 Technology 4.92%
3 Financials 4.81%
4 Communication Services 2.7%
5 Energy 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDTX icon
1051
Black Diamond Therapeutics
BDTX
$108M
$25.8K ﹤0.01%
+10,250
New +$19.8K
UP icon
1052
Wheels Up
UP
$137M
$25.8K ﹤0.01%
+1,205
New +$29.6K
IQ icon
1053
iQIYI
IQ
$984M
$25.2K ﹤0.01%
14,424
– –
CCCC icon
1054
C4 Therapeutics
CCCC
$367M
$22.6K ﹤0.01%
+15,836
New +$23K
MGNX icon
1055
MacroGenics
MGNX
$238M
$22K ﹤0.01%
+18,196
New +$26.4K
REKR icon
1056
Rekor Systems
REKR
$55.6M
$21K ﹤0.01%
+18,131
New +$19K
FLNA
1057
Filana Therapeutics
FLNA
$36.1M
$21K ﹤0.01%
+11,587
New +$20.6K
ZNTL icon
1058
Zentalis Pharmaceuticals
ZNTL
$256M
$19.5K ﹤0.01%
+16,830
New +$22.2K
CABA icon
1059
Cabaletta Bio
CABA
$351M
$19.5K ﹤0.01%
+12,840
New +$20K
CDLX icon
1060
Cardlytics
CDLX
$19.4M
$19K ﹤0.01%
+1,158
New +$20K
GUTS icon
1061
Fractyl Health
GUTS
$77.3M
$18.2K ﹤0.01%
+11,205
New +$18.1K
PLRX icon
1062
Pliant Therapeutics
PLRX
$66.9M
$18.1K ﹤0.01%
+15,631
New +$22.1K
GRWG icon
1063
GrowGeneration
GRWG
$91.9M
$17.4K ﹤0.01%
+18,541
New +$19.8K
APTO
1064
DELISTED
Aptose Biosciences, Inc.
APTO
$17.1K ﹤0.01%
+19,761
New +$33.8K
OPEN icon
1065
Opendoor
OPEN
$2.5B
$15.9K ﹤0.01%
+30,879
New +$22.3K
TCRX icon
1066
TScan Therapeutics
TCRX
$23M
$14.7K ﹤0.01%
+10,132
New +$14.6K
PYXS icon
1067
Pyxis Oncology
PYXS
$239M
$14.3K ﹤0.01%
+13,042
New +$14.7K
DXLG icon
1068
Destination XL Group
DXLG
$27.7M
$13.1K ﹤0.01%
+11,775
New +$12.9K
TPIC
1069
DELISTED
TPI Composites
TPIC
$12.9K ﹤0.01%
+14,967
New +$15.2K
ABOS icon
1070
Acumen Pharmaceuticals
ABOS
$162M
$12.8K ﹤0.01%
+11,018
New +$11.8K
CYPH
1071
Cypherpunk Technologies Inc
CYPH
$444M
$8.36K ﹤0.01%
28,159
– –
IAUX
1072
i-80 Gold Corp
IAUX
$1.51B
$8.08K ﹤0.01%
+13,509
New +$7.96K
AAL icon
1073
American Airlines Group
AAL
$9.18B
– –
-10,952
Closed -$116K
AAXJ icon
1074
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$4.03B
– –
-28,417
Closed -$2.1M
ABNB icon
1075
Airbnb
ABNB
$92.8B
– –
-2,888
Closed -$343K

Similar funds

DRW Securities's Q2 2025 Portfolio in Review

As of Q2 2025, DRW Securities held 1,313 positions worth $4.42B, up 23% from $3.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

DRW Securities's Q2 2025 filing shows 733 new, 204 increased, 127 reduced and 224 closed positions. Its largest new stake was Trump Media & Technology Group: 3,888,024 shares worth $70.1M. The largest sale was NVIDIA, an estimated $120M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Financials.

  • DRW Securities's largest Q2 2025 buy was Trump Media & Technology Group: 3,888,024 shares worth $70.1M.
  • DRW Securities added most to SPDR Gold Trust in Q2 2025, an estimated $58.8M increase.
  • DRW Securities's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $120M.
  • DRW Securities fully exited iShares MSCI Emerging Markets ETF in Q2 2025, selling an estimated $32.8M.
  • DRW Securities's ten largest holdings make up 47% of its $4.42B portfolio in Q2 2025.
  • DRW Securities opened 733 new positions and closed 224 in Q2 2025.
  • DRW Securities's portfolio value rose 23% quarter-over-quarter to $4.42B.

Based on DRW Securities's 13F filing for Q2 2025, filed 14 Aug 2025.